Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile
Amer Zeidan MBBS,MHS ‏عامر زيدان

@dr_amerzeidan

Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research @Yale. #Madridista. #AMLsm & #MDSsm. COI bit.ly/2YfwJ9V

ID: 1144997352148787201

calendar_today29-06-2019 15:53:36

15,15K Tweet

24,24K Takipçi

234 Takip Edilen

Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo
Amer Zeidan MBBS,MHS ‏عامر زيدان
@dr_amerzeidan

3 years ago

I applaud 👏 these revised ELN criteria which in my opinion fixed a major problem in 2017 criteria of “low ratio” FLT3 ITD Mutation being favorable risk when co-mutated with NPM1. Decisions based on FLT3 VAF are very tricky & all FLT3 is bad & should consider transplant #EHA2022

I applaud 👏 these revised ELN criteria which in my opinion fixed a major problem in 2017 criteria of “low ratio” FLT3 ITD Mutation being favorable risk when co-mutated with NPM1. Decisions based on FLT3 VAF are very tricky & all FLT3 is bad & should consider transplant #EHA2022